John Saharek's most recent trade in Harrow Health Inc was a trade of 277,200 Performance Stock Unit done . Disclosure was reported to the exchange on April 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harrow Health Inc | John Saharek P. | CEO & President, ImprimisRx | 03 Apr 2025 | 277,200 | 0 | - | - | Performance Stock Unit | ||
| Harrow Health Inc | John Saharek P. | CEO & President, ImprimisRx | 03 Apr 2025 | 277,200 | 576,863 (2%) | 1% | 0 | Common Stock | ||
| Harrow Health Inc | John Saharek P. | CEO & President, ImprimisRx | 03 Apr 2025 | 109,475 | 467,388 (1%) | 0% | 23.1 | 2,527,778 | Common Stock | |
| Harrow Health Inc | John Saharek | CEO of ImprimisRx | 11 Sep 2024 | 90,000 | 344,803 (1%) | 0% | 7.4 | 663,300 | Common stock | |
| Harrow Health Inc | John Saharek | CEO of ImprimisRx | 11 Sep 2024 | 90,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Harrow Health Inc | John Saharek | CEO of ImprimisRx | 11 Sep 2024 | 45,140 | 299,663 (1%) | 0% | 41.4 | 1,867,442 | Common stock | |
| Harrow Health Inc | John Saharek | CEO of ImprimisRx | 01 Mar 2024 | 5,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Harrow Health Inc | John Saharek | CEO of ImprimisRx | 01 Mar 2024 | 5,000 | 254,803 (1%) | 0% | 8.8 | 43,750 | Common stock | |
| Harrow Health Inc | Saharek John | CEO of ImprimisRx | 20 Feb 2024 | 30,000 | 262,419 (1%) | 0% | 10.7 | 320,100 | Common stock | |
| Harrow Health Inc | Saharek John | CEO of ImprimisRx | 20 Feb 2024 | 30,000 | 0 | - | - | RSU | ||
| Harrow Health Inc | John Saharek | CEO of ImprimisRx | 20 Feb 2024 | 12,616 | 249,803 (0%) | 0% | 10.7 | 134,613 | Common stock | |
| Harrow Health Inc | John Saharek | Chief Commercial Officer | 18 Jul 2023 | 277,200 | 0 | - | - | Performance Stock Unit | ||
| Harrow Health Inc | John Saharek | Chief Commercial Officer | 18 Jul 2023 | 277,200 | 331,277 (1%) | 1% | - | Common Stock | ||
| Harrow Health Inc | John Saharek | Chief Commercial Officer | 18 Jul 2023 | 109,080 | 222,197 (0%) | 0% | 18.2 | 1,988,528 | Common Stock | |
| Harrow Health Inc | John Saharek | Chief Commercial Officer | 03 Apr 2023 | 277,200 | 277,200 | - | - | Restricted Stock Unit | ||
| Harrow Health Inc | John Saharek | President, ImprimisRx | 19 Feb 2022 | 50,000 | 0 | - | - | Restricted Stock Unit | ||
| Harrow Health Inc | John Saharek | President, ImprimisRx | 19 Feb 2022 | 50,000 | 80,000 (0%) | 0% | - | Common Stock | ||
| Harrow Health Inc | John Saharek | President, ImprimisRx | 19 Feb 2022 | 25,923 | 54,077 (0%) | 0% | 7.9 | 204,014 | Common Stock |